Bioscope.ai is clinical decision support software that consolidates patient health data into a unified platform. It integrates whole-genome sequencing, microbiome analysis, lab biomarkers, and medical histories into a synthesized clinical view accessible before patient visits. With 30x genome sequencing coverage, the software analyzes variants against clinical databases. The AI provides evidence-based recommendations tied to patient data and peer-reviewed literature, examining 15 health dimensions including metabolic, cardiovascular, and cancer markers. The system flags pharmacogenomic variants for drug selection and dosing, synthesizes wearable data, and offers recommendations such as lifestyle protocols and specialist referrals. The software integrates with electronic medical records and can be operational within a week. HIPAA-compliant infrastructure ensures patient data ownership remains with patients, and the platform does not sell or share information externally.
